Mass balance and pharmacokinetics of an oral dose of 14C‐napabucasin in healthy adult male subjects
Abstract This phase 1, open‐label study assessed14C‐napabucasin absorption, metabolism, and excretion, napabucasin pharmacokinetics, and napabucasin metabolites (primary objectives); safety/tolerability were also evaluated. Eight healthy males (18-45 years) received a single oral 240‐mg napabucasin...
Shranjeno v:
Main Authors: | , , , , , , , |
---|---|
Format: | Knjiga |
Izdano: |
Wiley,
2021-02-01T00:00:00Z.
|
Teme: | |
Online dostop: | Connect to this object online. |
Oznake: |
Označite
Brez oznak, prvi označite!
|
Internet
Connect to this object online.3rd Floor Main Library
Signatura: |
A1234.567 |
---|---|
Kopija 1 | Prosto |